Is there a rationale for heparin use among severe COVID-19 patients?

Savioli, Felicio

Savioli, Felicio.

Savioli F; University of California San Diego, San Diego, United States.

Einstein (Sao Paulo) ; 18: eED5758, 2020.

Article in English, Portuguese | MEDLINE | ID: covidwho-524105

Subject(s)

Anticoagulants/therapeutic use; Coronavirus Infections/drug therapy; Heparin/therapeutic use; Pneumonia, Viral/drug therapy; COVID-19; Critical Illness; Cytokines/metabolism; Disseminated Intravascular Coagulation/drug therapy; Humans; Pandemics; Sepsis/drug therapy; Venous Thrombosis/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Heparin / Coronavirus Infections / Anticoagulants Limits: Humans Language: English / Portuguese Journal: Einstein (Sao Paulo) Year: 2020 Document Type: Article Affiliation country: Einstein_journal

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google